阴道单药米索前列醇与加重宫内Foley导管加阴道米索前列醇终止妊娠中期流产的随机对照试验

Ebtsam Desouky, Alaa El Feky, Amr A. Elsayed
{"title":"阴道单药米索前列醇与加重宫内Foley导管加阴道米索前列醇终止妊娠中期流产的随机对照试验","authors":"Ebtsam Desouky, Alaa El Feky, Amr A. Elsayed","doi":"10.21608/ebwhj.2019.17469.1024","DOIUrl":null,"url":null,"abstract":"Background: Termination of pregnancy (TOP) is defined as elective expulsion or extraction of products of conception from the uterus instead of spontaneous onset of the process irrespective of duration of pregnancy. Aim of the Work: to investigate whether the insertion of a weighted fluid filled trans-cervical Foley’s catheter in women undergoing midtrimester termination of pregnancy for various reasons; may further improve the effectiveness of vaginal misoprostol in terminating their pregnancies. Patients and Methods: A prospective, interventional, randomized controlled trial was conducted on a total number of 50 patients, divided into two groups; the first group (I) included 25 patients who received vaginal misoprostol, two tablets each contains 200 microgram misoprostol (Segma pharmaceuticals, Egypt), in the posterior vaginal fornix every four hours. Results: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects. Conclusion: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects.","PeriodicalId":224226,"journal":{"name":"Evidence Based Womenʼs Health Journal","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Randomized controlled trial between vaginal misoprostol alone versus weighted intrauterine Foley’s catheter and vaginal misoprostol in termination of mid-trimester abortion\",\"authors\":\"Ebtsam Desouky, Alaa El Feky, Amr A. Elsayed\",\"doi\":\"10.21608/ebwhj.2019.17469.1024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Termination of pregnancy (TOP) is defined as elective expulsion or extraction of products of conception from the uterus instead of spontaneous onset of the process irrespective of duration of pregnancy. Aim of the Work: to investigate whether the insertion of a weighted fluid filled trans-cervical Foley’s catheter in women undergoing midtrimester termination of pregnancy for various reasons; may further improve the effectiveness of vaginal misoprostol in terminating their pregnancies. Patients and Methods: A prospective, interventional, randomized controlled trial was conducted on a total number of 50 patients, divided into two groups; the first group (I) included 25 patients who received vaginal misoprostol, two tablets each contains 200 microgram misoprostol (Segma pharmaceuticals, Egypt), in the posterior vaginal fornix every four hours. Results: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects. Conclusion: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects.\",\"PeriodicalId\":224226,\"journal\":{\"name\":\"Evidence Based Womenʼs Health Journal\",\"volume\":\"27 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence Based Womenʼs Health Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/ebwhj.2019.17469.1024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence Based Womenʼs Health Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ebwhj.2019.17469.1024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:终止妊娠(TOP)被定义为选择性地从子宫排出或提取受孕产物,而不是与妊娠持续时间无关的自然发生的过程。本研究目的:探讨在因各种原因进行中期终止妊娠的妇女中,是否可插入加重充液经宫颈Foley导管;可能进一步提高阴道米索前列醇终止妊娠的有效性。患者和方法:采用前瞻性、干预性、随机对照试验,共50例患者,分为两组;第一组25例患者接受阴道米索前列醇治疗,每2片含200微克米索前列醇(Segma制药公司,埃及),每4小时在阴道后穹窿注射一次。结果:使用经颈加重Foley 's导管填充30ml生理盐水,可提高400µg阴道米索前列醇终止中期妊娠的有效性,这反映在诱导至分娩间隔更短,且副作用发生率无显著增加。结论:使用经颈加重Foley 's导管填充30ml生理盐水,可提高400µg阴道米索前列醇终止中期妊娠的有效性,可缩短引产间隔,且副作用发生率无显著增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Randomized controlled trial between vaginal misoprostol alone versus weighted intrauterine Foley’s catheter and vaginal misoprostol in termination of mid-trimester abortion
Background: Termination of pregnancy (TOP) is defined as elective expulsion or extraction of products of conception from the uterus instead of spontaneous onset of the process irrespective of duration of pregnancy. Aim of the Work: to investigate whether the insertion of a weighted fluid filled trans-cervical Foley’s catheter in women undergoing midtrimester termination of pregnancy for various reasons; may further improve the effectiveness of vaginal misoprostol in terminating their pregnancies. Patients and Methods: A prospective, interventional, randomized controlled trial was conducted on a total number of 50 patients, divided into two groups; the first group (I) included 25 patients who received vaginal misoprostol, two tablets each contains 200 microgram misoprostol (Segma pharmaceuticals, Egypt), in the posterior vaginal fornix every four hours. Results: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects. Conclusion: The use of a weighted trans-cervical Foley’s catheter filled with 30 ml saline improve the effectiveness of 400 µg vaginal misoprostol in terminating mid trimester pregnancies as reflected by a shorter induction to delivery interval with no significant increase in the incidence of side effects.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Hysteroscopy as a diagnostic tool in women with recurrent pregnancy loss, a prospective randomized controlled study Serum Soluble Endoglin Versus Serum Placental Growth Factor for Early Prediction of Preeclampsia Cervical cerclage for Pregnant Women at High-risk of Recurrent Preterm Birth can act beyond its Mechanical Action New ultrasound signs for prediction of early placental Insufficiency Efficacy and Safety of Preoperative Intravenous Tranexamic Acid to Reduce Blood Loss During and After Elective Lower‐Segment Cesarean Delivery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1